<DOC>
	<DOCNO>NCT02987777</DOCNO>
	<brief_summary>The aim study assess frequency PD-L1 expression stage III-IV ECs investigate correlation impact progression-free survival ( PFS ) , clinicopathological feature include microsatellite instability quantify stromal intraepithelial tumor-infiltrating CD8+ lymphocytes ( TILs )</brief_summary>
	<brief_title>Prognostic Impact Programmed Death Ligand-1 Expression Advanced Endometrial Cancer</brief_title>
	<detailed_description />
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<criteria>All patient consecutively enrol January 2004 December 2014 treat Endometrial cancer Stage IIIIV endometrial cancer available tissue block , include biopsy , hysterectomy specimen resection metastatic foci A patient record capture outside time frame January 2004 December 2014</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>